Literature DB >> 3533782

The ability to sensitize host cells for destruction by autologous complement is a general property of lipoteichoic acid.

B D Weinreb, G D Shockman, E H Beachey, A J Swift, J A Winkelstein.   

Abstract

Previous studies have demonstrated that lipoteichoic acid (LTA) from Streptococcus pneumoniae binds to erythrocytes and renders them susceptible to lysis by autologous complement. The present study was performed to determine whether LTA from two other gram-positive bacterial species had the ability to render mammalian cells susceptible to lysis by autologous complement. Human erythrocytes were sensitized with LTA from S. pneumoniae, Streptococcus pyogenes, or Lactobacillus fermentum. Under incubation in normal autologous serum, lysis was observed with each of the LTA-sensitized erythrocyte preparations. When erythrocytes from a C2-deficient patient were sensitized with the LTA preparations and then incubated in autologous, C2-deficient serum, the erythrocytes sensitized with S. pyogenes or L. fermentum LTA demonstrated relatively little lysis, whereas the erythrocytes sensitized with S. pneumoniae LTA yielded near-total lysis. After reconstitution of the C2-deficient serum with purified human C2, lysis was observed with all three LTA preparations. When erythrocytes from an agammaglobulinemic patient were sensitized with either the S. pyogenes or the L. fermentum LTA, they were not lysed in the presence of autologous agammaglobulinemic serum, whereas the erythrocytes sensitized with S. pneumoniae LTA were completely lysed. Serum obtained from the agammaglobulinemic patient after reconstitution with intravenous pooled gamma globulin was able to lyse autologous erythrocytes sensitized with each of the three LTA preparations. These results demonstrate that the ability to render host cells susceptible to lysis by autologous complement is a general property of LTA. Whether activation of the autologous complement occurs by the classical or alternative pathways and whether it is antibody dependent depends on the nature of the bacterial LTA.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3533782      PMCID: PMC260188          DOI: 10.1128/iai.54.2.494-499.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  Agglutination by human sera of erythrocytes incubated with streptococcal culture concentrates.

Authors:  T N HARRIS; S HARRIS
Journal:  J Bacteriol       Date:  1953-08       Impact factor: 3.490

2.  Activation of the alternative complement pathway by a streptococcal lipoteichoic acid.

Authors:  B A Fiedel; R W Jackson
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

Review 3.  Bacterial cell surface amphiphiles.

Authors:  A J Wicken; K W Knox
Journal:  Biochim Biophys Acta       Date:  1980-05-27

4.  Formation of extracellular lipoteichoic acid by oral streptococci and lactobacilli.

Authors:  J L Markham; K W Knox; A J Wicken; M J Hewett
Journal:  Infect Immun       Date:  1975-08       Impact factor: 3.441

5.  Evidence for restriction of the ability of complement to lyse homologous erythrocytes.

Authors:  J J Houle; E M Hoffmann
Journal:  J Immunol       Date:  1984-09       Impact factor: 5.422

6.  Erythrocyte binding properties of streptococcal lipoteichoic acids.

Authors:  E H Beachey; J B Dale; W A Simpson; J D Evans; K W Knox; I Ofek; A J Wicken
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

7.  Characteristics of the binding of streptococcal lipoteichoic acid to human oral epithelial cells.

Authors:  W A Simpson; I Ofek; C Sarasohn; J C Morrison; E H Beachey
Journal:  J Infect Dis       Date:  1980-04       Impact factor: 5.226

8.  Prevention of complement activation on the homologous cell membrane of nucleated cells as well as erythrocytes.

Authors:  H Okada; H Tanaka; N Okada
Journal:  Eur J Immunol       Date:  1983-04       Impact factor: 5.532

9.  Pneumococcal C-substance, a ribitol teichoic acid containing choline phosphate.

Authors:  D E Brundish; J Baddiley
Journal:  Biochem J       Date:  1968-12       Impact factor: 3.857

10.  Cell membrane-binding properties of group A streptococcal lipoteichoic acid.

Authors:  I Ofek; E H Beachey; W Jefferson; G L Campbell
Journal:  J Exp Med       Date:  1975-05-01       Impact factor: 14.307

View more
  6 in total

1.  Stimulation of monokine production by lipoteichoic acids.

Authors:  S Bhakdi; T Klonisch; P Nuber; W Fischer
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

Review 2.  Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.

Authors:  Edwin S Van Amersfoort; Theo J C Van Berkel; Johan Kuiper
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

3.  Purification and characterization of Streptococcus adjacens (nutritionally variant Streptococcus serotype II) group antigen.

Authors:  P A Sieling; I van de Rijn
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

4.  Heterogeneity of lipoteichoic acid detected by anion exchange chromatography.

Authors:  K Leopold; W Fischer
Journal:  Arch Microbiol       Date:  1992       Impact factor: 2.552

5.  Lipoteichoic acid-antilipoteichoic acid complexes induce superoxide generation by human neutrophils.

Authors:  I Ginsburg; S E Fligiel; P A Ward; J Varani
Journal:  Inflammation       Date:  1988-12       Impact factor: 4.092

6.  Macrophage response to bacteria: induction of marked secretory and cellular activities by lipoteichoic acids.

Authors:  R Keller; W Fischer; R Keist; S Bassetti
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.